Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve
Directs the filling of the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) with active pharmaceutical ingredients and finished doses for the most critical medicines, produced domestically.
Section by Section
What each section does, and how they differ.
Addresses pharmaceutical supply chain resilience by using the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) to maintain supplies of critical active pharmaceutical ingredients and finished drugs.
Directs ASPR to develop a list of approximately 26 critical drugs and source or manufacture active pharmaceutical ingredients to fill the SAPIR within specified timelines using available funding.
Requires ASPR to update its essential medicines list and coordinate with agencies to maintain pharmaceutical supply chain capabilities for national security.